Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence
There is good epidemiological evidence that patients with autoimmune rheumatic disease states, particularly rheumatoid arthritis, have an increased risk of cardiovascular morbidity and mortality when compared to the general population. The presence of a chronic systemic proinflammatory state in this...
Saved in:
| Main Authors: | Arduino A. Mangoni, Angelo Zinellu, Salvatore Sotgia, Ciriaco Carru, Matteo Piga, Gian Luca Erre |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2017/9632846 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
by: Alberto Floris, et al.
Published: (2018-01-01) -
A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis
by: Arduino A. Mangoni, et al.
Published: (2025-12-01) -
Evaluation of Global Genomic DNA Methylation in Human Whole Blood by Capillary Electrophoresis UV Detection
by: Angelo Zinellu, et al.
Published: (2017-01-01) -
sCD40 and sCD40L as candidate biomarkers of rheumatic diseases: a systematic review and meta-analysis with meta-regression
by: Angelo Zinellu, et al.
Published: (2025-03-01) -
Endostatin as a biomarker of systemic sclerosis: insights from a systematic review and meta-analysis
by: Arduino A. Mangoni, et al.
Published: (2024-12-01)